End-of-day quote
Australian S.E.
03:30:00 08/05/2024 am IST
|
5-day change
|
1st Jan Change
|
0.018
AUD
|
+12.50%
|
|
+5.88%
|
-10.00%
|
Fiscal Period: June |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
100.6
|
26.09
|
40.3
|
35.69
|
35.26
|
21.49
|
-
|
-
|
Enterprise Value (EV)
1 |
76.6
|
19.48
|
27.91
|
26.75
|
26.03
|
14.29
|
12.29
|
17.99
|
P/E ratio
|
-5.1
x
|
-1.89
x
|
-12.7
x
|
-16.1
x
|
-2.45
x
|
-1.64
x
|
-2
x
|
-6
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
8.26
x
|
2.06
x
|
1.7
x
|
2.24
x
|
1.83
x
|
1.85
x
|
5.97
x
|
4.78
x
|
EV / Revenue
|
6.29
x
|
1.54
x
|
1.18
x
|
1.68
x
|
1.35
x
|
1.23
x
|
3.41
x
|
4
x
|
EV / EBITDA
|
-4.89
x
|
-1.61
x
|
-124
x
|
-2.61
x
|
-3.21
x
|
-1.86
x
|
-0.96
x
|
-4.5
x
|
EV / FCF
|
-3.69
x
|
-1.41
x
|
11.5
x
|
-1.65
x
|
-
|
-2.51
x
|
-1.18
x
|
-4.28
x
|
FCF Yield
|
-27.1%
|
-71.2%
|
8.7%
|
-60.4%
|
-
|
-39.9%
|
-84.6%
|
-23.3%
|
Price to Book
|
-
|
-
|
-
|
3.3
x
|
3.69
x
|
-
|
-
|
-
|
Nbr of stocks (in thousands)
|
3,94,316
|
3,95,249
|
4,52,824
|
5,49,078
|
7,19,584
|
11,94,032
|
-
|
-
|
Reference price
2 |
0.2550
|
0.0660
|
0.0890
|
0.0650
|
0.0490
|
0.0180
|
0.0180
|
0.0180
|
Announcement Date
|
25/07/19
|
31/07/20
|
28/07/21
|
29/07/22
|
28/08/23
|
-
|
-
|
-
|
Fiscal Period: June |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
12.17
|
12.66
|
23.68
|
15.91
|
19.31
|
11.6
|
3.6
|
4.5
|
EBITDA
1 |
-15.65
|
-12.08
|
-0.225
|
-10.25
|
-8.114
|
-7.7
|
-12.8
|
-4
|
EBIT
1 |
-18.27
|
-15.32
|
-3.377
|
-13.48
|
-9.962
|
-8.1
|
-13.2
|
-4.4
|
Operating Margin
|
-150.11%
|
-120.93%
|
-14.26%
|
-84.74%
|
-51.6%
|
-69.83%
|
-366.67%
|
-97.78%
|
Earnings before Tax (EBT)
1 |
-
|
-
|
-
|
-1.93
|
-11.36
|
-8.2
|
-13.3
|
-4.5
|
Net income
1 |
-20.06
|
-13.94
|
-2.97
|
-1.93
|
-11.36
|
-8.2
|
-13.3
|
-4.5
|
Net margin
|
-164.8%
|
-110.09%
|
-12.54%
|
-12.13%
|
-58.84%
|
-70.69%
|
-369.44%
|
-100%
|
EPS
2 |
-0.0500
|
-0.0350
|
-0.007000
|
-0.004030
|
-0.0200
|
-0.0110
|
-0.009000
|
-0.003000
|
Free Cash Flow
1 |
-20.78
|
-13.86
|
2.428
|
-16.17
|
-
|
-5.7
|
-10.4
|
-4.2
|
FCF margin
|
-170.73%
|
-109.42%
|
10.26%
|
-101.6%
|
-
|
-49.14%
|
-288.89%
|
-93.33%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
25/07/19
|
31/07/20
|
28/07/21
|
29/07/22
|
28/08/23
|
-
|
-
|
-
|
Fiscal Period: June |
2020 S1
|
2020 S2
|
2021 S1
|
2021 S2
|
2023 Q2
|
2023 S2
|
---|
Net sales
|
4.021
|
8.644
|
13.69
|
9.989
|
-
|
10.15
|
EBITDA
|
-7.999
|
-4.081
|
0.713
|
-0.938
|
-
|
-
|
EBIT
|
-9.615
|
-5.701
|
-0.876
|
-2.501
|
-
|
-
|
Operating Margin
|
-239.12%
|
-65.95%
|
-6.4%
|
-25.04%
|
-
|
-
|
Earnings before Tax (EBT)
|
-
|
-
|
-
|
-
|
-
|
-
|
Net income
1 |
-10.32
|
-3.624
|
0.046
|
-3.016
|
-4.786
|
-
|
Net margin
|
-256.63%
|
-41.93%
|
0.34%
|
-30.19%
|
-
|
-
|
EPS
2 |
-
|
-
|
-
|
-0.007000
|
-0.000100
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
31/01/20
|
31/07/20
|
29/01/21
|
28/07/21
|
10/02/23
|
28/08/23
|
Fiscal Period: June |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
24
|
6.61
|
12.4
|
8.94
|
9.23
|
7.2
|
9.2
|
3.5
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-20.8
|
-13.9
|
2.43
|
-16.2
|
-
|
-5.7
|
-10.4
|
-4.2
|
ROE (net income / shareholders' equity)
|
-
|
-
|
-
|
-
|
-112%
|
-
|
-
|
-
|
ROA (Net income/ Total Assets)
|
-39%
|
-31.7%
|
-8.61%
|
-6.57%
|
-46.2%
|
-
|
-
|
-
|
Assets
1 |
51.38
|
44.04
|
34.5
|
29.39
|
24.61
|
-
|
-
|
-
|
Book Value Per Share
|
-
|
-
|
-
|
0.0200
|
0.0100
|
-
|
-
|
-
|
Cash Flow per Share
2 |
-
|
-
|
-
|
-0.0300
|
-0.0100
|
-0.0100
|
-0.0100
|
-0
|
Capex
1 |
0.58
|
0.26
|
0.33
|
0.07
|
0.14
|
0.1
|
0.1
|
-
|
Capex / Sales
|
4.73%
|
2.05%
|
1.4%
|
0.41%
|
0.71%
|
0.86%
|
2.78%
|
-
|
Announcement Date
|
25/07/19
|
31/07/20
|
28/07/21
|
29/07/22
|
28/08/23
|
-
|
-
|
-
|
|
1st Jan change
|
Capi.
|
---|
| -10.00% | 14.13M | | +32.95% | 698B | | +26.51% | 568B | | -4.97% | 358B | | +18.83% | 328B | | +3.54% | 283B | | +15.70% | 238B | | +6.68% | 203B | | -9.08% | 198B | | +6.70% | 165B |
Other Pharmaceuticals
|